Progressive decline of hybrid BCR/ABL mRNA molecules in bone marrow mononuclear cells from a CML patient (no. 1 in Table 2) who had a complete hematologic response after IFN- therapy. BCR/ABL values are corrected for the percentage of Ph⁺cells.